Vimarsana
Biggest News Aggregation in the World

62855j10 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 62855j10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 62855j10 Today - Breaking & Trending Today

Federated Hermes Inc. Sells 1,533 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN) - Vimarsana News

Federated Hermes Inc. Sells 1,533 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)

Federated Hermes Inc. decreased its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 2.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 55,009 shares of the company’s stock after selling 1,533 shares during the quarter. […]

Myriad Genetics, Inc. (NASDAQ:MYGN) Given Average Rating of "Hold" by Brokerages - Vimarsana News

Myriad Genetics, Inc. (NASDAQ:MYGN) Given Average Rating of "Hold" by Brokerages

Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have received an average recommendation of “Hold” from the six analysts that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and three have assigned a buy recommendation to the company. […]

Brokerages Set Myriad Genetics, Inc. (NASDAQ:MYGN) Price Target at $23.17 - Vimarsana News

Brokerages Set Myriad Genetics, Inc. (NASDAQ:MYGN) Price Target at $23.17

Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have been given an average rating of “Hold” by the six brokerages that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to […]

Myriad Genetics (NASDAQ:MYGN) Releases Earnings Results, Beats Expectations By $0.03 EPS - Vimarsana News

Myriad Genetics (NASDAQ:MYGN) Releases Earnings Results, Beats Expectations By $0.03 EPS

Myriad Genetics (NASDAQ:MYGN – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $0.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.03, Briefing.com reports. The business had revenue of $196.60 million for the quarter, compared to analysts’ expectations of $194.80 million. Myriad Genetics had […]

Myriad Genetics (NASDAQ:MYGN) Releases FY 2024 Earnings Guidance - Vimarsana News

Myriad Genetics (NASDAQ:MYGN) Releases FY 2024 Earnings Guidance

Myriad Genetics (NASDAQ:MYGN – Get Free Report) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 0.000-0.050 for the period, compared to the consensus estimate of -0.010. The company issued revenue guidance of $820.0 million-$840.0 million, compared to the consensus revenue estimate of […]